Related Experiment Video
Updated: Jun 6, 2025

04:56
Laryngeal Mask Airway LMA Placement in a Neonatal Patient Simulator Using a Non-Inflatable Supraglottic Airway SGA
Published on: July 14, 2023
2.7K
Implementation mapping to plan for the Supraglottic Airway for Resuscitation (SUGAR) trial
Gwendolyn M Lawson1,2, Elizabeth E Foglia3, Sura Lee3
1Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA, USA. lawsong@chop.edu.
Implementation Science Communications
|November 28, 2024
Summary
Supraglottic airway (SA) devices are more effective than face masks for neonatal resuscitation but rarely used. Implementation mapping identified barriers like insufficient training and lack of perceived need, guiding strategy selection for a hybrid trial.
Area of Science:
- Neonatal Resuscitation
- Implementation Science
- Medical Device Adoption
Background:
- Positive pressure ventilation (PPV) is critical for neonatal resuscitation.
- Supraglottic airway (SA) devices show higher effectiveness than face masks in reducing PPV failure and intubation needs.
- Despite evidence, SA device use is infrequent in US hospital delivery rooms.
Purpose of the Study:
- To identify barriers and facilitators to supraglottic airway (SA) device use in neonatal resuscitation.
- To develop and refine implementation strategies for increasing SA device adoption.
- To inform the design of a pragmatic hybrid effectiveness-implementation trial.
Main Methods:
- Implementation mapping was employed to systematically identify barriers and facilitators.
- The Consolidated Framework for Implementation Research (CFIR) was used to organize findings.
- Iterative feedback from clinicians and administrators refined implementation strategies.
Main Results:
- Key barriers included mixed perceptions of SA devices, insufficient education/training, and lack of perceived need for alternatives.
- Implementation strategies were selected based on identified barriers and facilitators.
- The process led to the selection of two sets of strategies for a hybrid trial.
Conclusions:
- Implementation mapping offers a systematic, partner-engaged approach for selecting strategies in hybrid trial design.
- This process can be an exemplar for other healthcare settings aiming to improve device adoption.
- Addressing identified barriers is crucial for successful integration of effective SA devices into routine practice.

